AI In Life Science Analytics Market Size, Share, and Trends 2025 to 2034

The AI in Life Science Analytics Market is projected to grow from USD 2.46 billion in 2025 to USD 6.28 billion by 2034, at a CAGR of 10.96%. Growth is driven by big data, precision medicine, and AI-led breakthroughs in R&D and drug discovery. North America leads, with Asia-Pacific expanding fastest.

Last Updated : June 2025  |  Report Code : 3642  |  Category : Healthcare  |  Format : PDF / PPT / Excel

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on AI in Life Science Analytics Market 

5.1. COVID-19 Landscape: AI in Life Science Analytics Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global AI in Life Science Analytics Market, By Component

8.1. AI in Life Science Analytics Market, by Component

8.1.1. Software

8.1.1.1. Market Revenue and Forecast

8.1.2. Hardware

8.1.2.1. Market Revenue and Forecast

8.1.3. Services

8.1.3.1. Market Revenue and Forecast

Chapter 9. Global AI in Life Science Analytics Market, By End-user

9.1. AI in Life Science Analytics Market, by End-user

9.1.1. Medical Devices

9.1.1.1. Market Revenue and Forecast

9.1.2. Pharmaceutical

9.1.2.1. Market Revenue and Forecast

9.1.3. Biotechnology

9.1.3.1. Market Revenue and Forecast

9.1.4. Others

9.1.4.1. Market Revenue and Forecast

Chapter 10. Global AI in Life Science Analytics Market, By Application 

10.1. AI in Life Science Analytics Market, by Application

10.1.1. Research and Development

10.1.1.1. Market Revenue and Forecast

10.1.2. Sales and Marketing support

10.1.2.1. Market Revenue and Forecast

10.1.3. Supply chain analytics

10.1.3.1. Market Revenue and Forecast

10.1.4. Others

10.1.4.1. Market Revenue and Forecast

Chapter 11. Global AI in Life Science Analytics Market, By Deployment 

11.1. AI in Life Science Analytics Market, by Deployment

11.1.1. On-premise

11.1.1.1. Market Revenue and Forecast

11.1.2. Cloud

11.1.2.1. Market Revenue and Forecast

Chapter 12. Global AI in Life Science Analytics Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Component

12.1.2. Market Revenue and Forecast, by End-user

12.1.3. Market Revenue and Forecast, by Application

12.1.4. Market Revenue and Forecast, by Deployment

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Component

12.1.5.2. Market Revenue and Forecast, by End-user

12.1.5.3. Market Revenue and Forecast, by Application

12.1.5.4. Market Revenue and Forecast, by Deployment

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Component

12.1.6.2. Market Revenue and Forecast, by End-user

12.1.6.3. Market Revenue and Forecast, by Application

12.1.6.4. Market Revenue and Forecast, by Deployment

12.2. Europe

12.2.1. Market Revenue and Forecast, by Component

12.2.2. Market Revenue and Forecast, by End-user

12.2.3. Market Revenue and Forecast, by Application

12.2.4. Market Revenue and Forecast, by Deployment

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Component

12.2.5.2. Market Revenue and Forecast, by End-user

12.2.5.3. Market Revenue and Forecast, by Application

12.2.5.4. Market Revenue and Forecast, by Deployment

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Component

12.2.6.2. Market Revenue and Forecast, by End-user

12.2.6.3. Market Revenue and Forecast, by Application

12.2.6.4. Market Revenue and Forecast, by Deployment

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Component

12.2.7.2. Market Revenue and Forecast, by End-user

12.2.7.3. Market Revenue and Forecast, by Application

12.2.7.4. Market Revenue and Forecast, by Deployment

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Component

12.2.8.2. Market Revenue and Forecast, by End-user

12.2.8.3. Market Revenue and Forecast, by Application

12.2.8.4. Market Revenue and Forecast, by Deployment

12.3. APAC

12.3.1. Market Revenue and Forecast, by Component

12.3.2. Market Revenue and Forecast, by End-user

12.3.3. Market Revenue and Forecast, by Application

12.3.4. Market Revenue and Forecast, by Deployment

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Component

12.3.5.2. Market Revenue and Forecast, by End-user

12.3.5.3. Market Revenue and Forecast, by Application

12.3.5.4. Market Revenue and Forecast, by Deployment

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Component

12.3.6.2. Market Revenue and Forecast, by End-user

12.3.6.3. Market Revenue and Forecast, by Application

12.3.6.4. Market Revenue and Forecast, by Deployment

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Component

12.3.7.2. Market Revenue and Forecast, by End-user

12.3.7.3. Market Revenue and Forecast, by Application

12.3.7.4. Market Revenue and Forecast, by Deployment

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Component

12.3.8.2. Market Revenue and Forecast, by End-user

12.3.8.3. Market Revenue and Forecast, by Application

12.3.8.4. Market Revenue and Forecast, by Deployment

12.4. MEA

12.4.1. Market Revenue and Forecast, by Component

12.4.2. Market Revenue and Forecast, by End-user

12.4.3. Market Revenue and Forecast, by Application

12.4.4. Market Revenue and Forecast, by Deployment

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Component

12.4.5.2. Market Revenue and Forecast, by End-user

12.4.5.3. Market Revenue and Forecast, by Application

12.4.5.4. Market Revenue and Forecast, by Deployment

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Component

12.4.6.2. Market Revenue and Forecast, by End-user

12.4.6.3. Market Revenue and Forecast, by Application

12.4.6.4. Market Revenue and Forecast, by Deployment

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Component

12.4.7.2. Market Revenue and Forecast, by End-user

12.4.7.3. Market Revenue and Forecast, by Application

12.4.7.4. Market Revenue and Forecast, by Deployment

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Component

12.4.8.2. Market Revenue and Forecast, by End-user

12.4.8.3. Market Revenue and Forecast, by Application

12.4.8.4. Market Revenue and Forecast, by Deployment

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Component

12.5.2. Market Revenue and Forecast, by End-user

12.5.3. Market Revenue and Forecast, by Application

12.5.4. Market Revenue and Forecast, by Deployment

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Component

12.5.5.2. Market Revenue and Forecast, by End-user

12.5.5.3. Market Revenue and Forecast, by Application

12.5.5.4. Market Revenue and Forecast, by Deployment

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Component

12.5.6.2. Market Revenue and Forecast, by End-user

12.5.6.3. Market Revenue and Forecast, by Application

12.5.6.4. Market Revenue and Forecast, by Deployment

Chapter 13. Company Profiles

13.1. Indegene

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Lexalytics

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Databricks

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. SAS Institute Inc.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Sisense

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. IQVIA

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. IBM

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Sorcero

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global AI in life science analytics market size is expected to increase USD 6.28 billion by 2034 from USD 2.22 billion in 2024.

The global AI in life science analytics market will register growth rate of 10.98% between 2025 and 2034.

The major players operating in the AI in life science analytics market are Indegene, Lexalytics, Databricks, SAS Institute Inc., Sisense, IQVIA, IBM, Sorcero, and Others.

The driving factor of the AI in life science analytics market is the explosion of data in life sciences.

North America region will lead the global AI in life science analytics market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client